NASDAQ:NH - NantHealth Stock Price, Forecast & News

NantHealth trades on the NASDAQ under the ticker symbol "NH."

NantHealth Inc (NASDAQ:NH) released its quarterly earnings data on Thursday, August, 9th. The company reported ($0.10) EPS for the quarter, beating the Zacks' consensus estimate of ($0.11) by $0.01. The company earned $22.05 million during the quarter, compared to the consensus estimate of $24.50 million. NantHealth had a negative net margin of 105.82% and a negative return on equity of 10,106.10%. View NantHealth's Earnings History.

NantHealth is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for NantHealth.

1 brokers have issued 1-year price targets for NantHealth's shares. Their forecasts range from $1.00 to $1.00. On average, they anticipate NantHealth's stock price to reach $1.00 in the next year. This suggests that the stock has a possible downside of 43.8%. View Analyst Price Targets for NantHealth.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.

Headlines about NH stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. NantHealth earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the next few days. View News Stories for NantHealth.

NantHealth saw a decrease in short interest in January. As of January 31st, there was short interest totalling 170,600 shares, a decrease of 23.9% from the January 15th total of 224,300 shares. Based on an average daily volume of 236,700 shares, the short-interest ratio is presently 0.7 days. Currently, 0.5% of the shares of the stock are short sold. View NantHealth's Current Options Chain.

Some companies that are related to NantHealth include Trivago (TRVG), Carbonite (CARB), Cars.com (CARS), Tucows (TCX), ZIX (ZIXI), Liberty Tripadvisor Holdings Inc Series A (LTRPA), Sohu.com (SOHU), CooTek (Cayman) (CTK), Brightcove (BCOV), GTY Technology (GTYH), Ooma (OOMA), Fang (SFUN), Castlight Health (CSLT), FRONTEO (FTEO) and Park City Group (PCYG).

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include Nantkwest (NK), Trevena (TRVN), Progenics Pharmaceuticals (PGNX), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO), Akorn (AKRX), Anavex Life Sciences (AVXL), Gilead Sciences (GILD) and Neos Therapeutics (NEOS).

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

NantHealth's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.46%), Jacobs Levy Equity Management Inc. (0.08%), Miracle Mile Advisors LLC (0.05%), Paragon Wealth Strategies LLC (0.03%) and Bank of America Corp DE (0.03%). View Institutional Ownership Trends for NantHealth.

NH stock was sold by a variety of institutional investors in the last quarter, including Miracle Mile Advisors LLC. View Insider Buying and Selling for NantHealth.

NH stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Jacobs Levy Equity Management Inc., Paragon Wealth Strategies LLC and Bank of America Corp DE. View Insider Buying and Selling for NantHealth.

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NH stock can currently be purchased for approximately $1.78.

NantHealth has a market capitalization of $196.90 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.

The official website for NantHealth is http://www.nanthealth.com/.

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]